EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Flavone-Based Anticancer Agents: Advances in Structure–Activity Relationships and Multitarget Mechanisms for Drug Design (2015–Present)

Mmakwena M Mmonwa iD, Malose J Mphahlele iD

Molecules · 27.10.2026 · 31 (21) · 3866

DOI: 10.3390/molecules31213866 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 27.10.2026. Verfasst von Mmakwena M Mmonwa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, KwaDlangezwa Campus, University of Zululand, Empangeni 3886, South Africa. Hauptthemen laut MEDLINE: Flavones, Antineoplastic Agents, Drug Design, Neoplasms. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, University of Zululand, University of South Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

2-Phenylchromen-4-one–based compounds (e.g., flavones and flavonols) have emerged as privileged scaffolds in anticancer drug discovery owing to their ability to modulate multiple molecular targets involved in tumour initiation, progression, metastasis, angiogenesis, immune evasion, and therapeutic resistance. This review correlates key structural modifications or the structure–activity relationships (SARs) of the naturally occurring and synthetic flavone analogues to enhance anticancer activity across diverse molecular targets from 2015 till present. The influence of hydroxylation, methoxylation, halogenation, sulphur bioisosteric replacement, heterocyclic substitution, and hybridisation strategies on target affinity, selectivity, pharmacokinetics, and biological efficacy is critically discussed. Emphasis is placed on flavone core interactions with various targets, highlighting representative lead compounds and their biological activities. Recent advances in computational modelling, molecular docking, and hybrid drug design further demonstrate the value of SAR-guided optimisation for improving potency and overcoming drug resistance. Collectively, the evidence establishes flavones as versatile multitarget anticancer scaffolds and provides a rational framework for developing next-generation flavone-based therapeutics with improved efficacy, selectivity, and drug-like properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonesAntineoplastic AgentsDrug DesignNeoplasmsHumansStructure-Activity RelationshipMolecular Docking SimulationMolecular StructureAnimals

Stichwörter der Autor:innen

anticancer activitybiochemical targetsflavonesflavonolsstructure–activity relationship

Substanzen

FlavonesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, KwaDlangezwa Campus, University of Zululand, Empangeni 3886, South Africa.
  • College of Science, Engineering and Technology, University of South Africa, Private Bag X06, Florida 1710, South Africa.

ORCID-Profile: Mmakwena M Mmonwa, Malose J Mphahlele

Förderung

  • National Research Foundation
  • University of Zululand
  • University of South Africa
  • National Research Foundation (NRF) in South Africa

Zitieren

APA

Mmonwa, M. M., & Mphahlele, M. J. (2026). Flavone-Based Anticancer Agents: Advances in Structure–Activity Relationships and Multitarget Mechanisms for Drug Design (2015–Present). Molecules, 31(21), 3866. https://doi.org/10.3390/molecules31213866

Vancouver

Mmonwa MM, Mphahlele MJ. Flavone-Based Anticancer Agents: Advances in Structure–Activity Relationships and Multitarget Mechanisms for Drug Design (2015–Present). Molecules. 2026;31(21):3866. doi:10.3390/molecules31213866

BibTeX
@article{Mmonwa2026,
  author = {Mmonwa, Mmakwena M and Mphahlele, Malose J},
  title = {Flavone-Based Anticancer Agents: Advances in Structure–Activity Relationships and Multitarget Mechanisms for Drug Design (2015–Present)},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {21},
  pages = {3866},
  doi = {10.3390/molecules31213866}
}
Kostenlos starten →